QUIDELORTHO CORP (QDEL) Debt / Equity
- 2025-12-28: Debt/Equity Ratio 1.5.
- 2024-12-29: Debt/Equity Ratio 0.95.
- 2023-12-31: Debt/Equity Ratio 0.51.
- 2023-01-01: Debt/Equity Ratio 0.58.
Complete source-backed debt/equity ratio history.
- Available history
- 2023-01-01 to 2025-12-28
- Data captured
Historical Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|---|
| 2025-12-28 | 1.5 |
| 2024-12-29 | 0.95 |
| 2023-12-31 | 0.51 |
| 2023-01-01 | 0.58 |
Annual Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|---|
| 2025-12-28 | 1.5 |
| 2024-12-29 | 0.95 |
| 2023-12-31 | 0.51 |
| 2023-01-01 | 0.58 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |